Biotech Bros artwork

More Issues for CRISPR Therapeutics: Another CAR-T Failure in Solid Tumors

Biotech Bros

English - July 05, 2022 12:00 - 45 minutes - 31 MB
Investing Business Health & Fitness Medicine biotech investing money finance get rich markets comedy health healthcare Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: How to Navigate Biotech with Maxim Jacobs
Next Episode: Acquisitions in the $XBI, a Second Chance at bat for $AMLX, and a Potential Cure for Huntington's

This week on the podcast Agustin discusses the recent data release from CRISPR Therapeutics, Galapagos' CAR-T cell therapy acquisition, and the over-saturation of SCD therapies entering the market. 


If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com

All Business. No Boundaries.
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...

Listen on: Apple Podcasts   Spotify

If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com

Twitter Mentions